OpenVSafe by OpenVAERS
Search V-safe

8UR-19440-80052

2 vaccinations 4 coded responses 15 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
975 / OR
Registered
2021-03-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-10
    Dose 1 — Moderna
  2. 2021-03-11
    Registered in v-safe
  3. 2021-03-11
    Dose 2 — Moderna
  4. 2021-03-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fever · Headache
    Adult check-in
  5. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthenia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Joint pains
    Adult check-in
  7. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · Chills, Fatigue or tiredness
    Adult check-in
  9. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness
    Adult check-in
  10. 2021-03-18
    Health check-in — day 7, dose 2
    Feeling: Poor · Fever · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  11. 2021-03-25
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-04-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-08
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-04-15
    Survey response — day 35, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Intense fatigue. This very well may be caused by transitioning to in person teaching, with all of the replanning, adjusting, extra hours sanitizing, and policing I have to do of students now.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-09-09
    Survey response — 6 months, dose 2
    MedDRA: Balance disorder, Confusional state, Fatigue, Muscle disorder, Nausea, Tinnitus, VIIIth nerve injury, Vertigo, Viral labyrinthitis, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Viral labrynthitus - permanent damage to one vestibular nerve, resulting in loss of balance, tinitus, vertigo, nausea, vomiting, confusion, muscular problems in the neck, and fatigue.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-09-09
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  19. 2021-09-10
  20. 2021-09-13
  21. 2022-03-12
    Survey response — 12 months, dose 2
    MedDRA: Delivery, Viral labyrinthitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Hospitalization
    Free text: Gave birth. Recurring viral labrynthitus
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-03-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
  23. 2022-03-14

Vaccinations

DoseDateManufacturerCo-administered
12021-02-10Moderna
22021-03-11Moderna

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-12

Systemic reaction (other): Weakness

Release 7 — day 35, dose 2

2021-04-15

Symptoms: Intense fatigue. This very well may be caused by transitioning to in person teaching, with all of the replanning, adjusting, extra hours sanitizing, and policing I have to do of students now.

Release 9 — 6 months, dose 2

2021-09-09

Symptoms: Viral labrynthitus - permanent damage to one vestibular nerve, resulting in loss of balance, tinitus, vertigo, nausea, vomiting, confusion, muscular problems in the neck, and fatigue.

Release 11 — 12 months, dose 2

2022-03-12

Symptoms: Gave birth. Recurring viral labrynthitus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBalance disorder · · ✓
SDConfusional state · · ✓
SDDelivery · · ✓
SDFatigue ✓ ✓ ✓
SDMuscle disorder · · ✓
SDNausea · · ✓
SDTinnitus · · ✓
SDVertigo · · ✓
SDVIIIth nerve injury · · ✓
SDViral labyrinthitis · · ✓
SDVomiting · · ✓
SROAsthenia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release